...
首页> 外文期刊>Pharmacoepidemiology and drug safety >The population risk of fractures attributable to oral corticosteroids.
【24h】

The population risk of fractures attributable to oral corticosteroids.

机译:口服皮质类固醇可导致人群骨折的风险。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: Previous studies have indicated a relationship between oral corticosteroid use and the risk of fracture, although without population-based comparators or exact dose information. The aim was to estimate the relative and population attributable risk (PAR) of admission for non-traumatic fracture among users of corticosteroids. METHODS: The design was a retrospective cohort study of the population of Tayside, Scotland aged 18 or over and resident between 1 January 1993 and 31 January 1997 (n = 280 645). Subjects included were those who redeemed one or more prescriptions for oral corticosteroids compared with those not prescribed corticosteroids (oral or inhaled) in the population. The main outcome measure was the PAR and relative risk of hospital admissions for non-traumatic fracture. RESULTS: Approximately 7.5% of the population received prescriptions for oral corticosteroids. There was a significantly higher risk of fracture in the oral corticosteroid cohort when exposed to drugs compared with the general population (RR = 1.90, 95% CI 1.68, 2.16), after adjustment. Women were at higher risk than men, especially for vertebral fractures (RR = 5.19, 95% CI 2.95, 9.16). Previous fracture, Parkinsonian and anti-epileptic medication were significantly associated with higher risk, while HRT, NSAIDS and statins were associated with lower risk. An estimate of one in six vertebral and 1 in 13 non-vertebral fractures could be due to oral corticosteroid use in the population. CONCLUSIONS: The important public health impact of oral corticosteroids, especially in women needs to be addressed. Greater use of medication to ameliorate the adverse effects of these widely-used drugs is advocated.
机译:目的:先前的研究表明口服皮质类固醇激素使用与骨折风险之间存在关联,尽管没有基于人群的比较者或确切的剂量信息。目的是评估皮质类固醇使用者使用非创伤性骨折的相对风险和人群归因风险(PAR)。方法:该设计是一项回顾性队列研究,研究对象是1993年1月1日至1997年1月31日期间居住在苏格兰Tayside的18岁或以上人口(n = 280 645)。所包括的受试者是那些与人群中未处方皮质类固醇(口服或吸入)相比,使用一种或多种口服皮质类固醇处方的受试者。主要结局指标是非创伤性骨折的PAR和入院相对风险。结果:大约7.5%的人口接受了口服皮质类固醇的处方。调整后,与一般人群相比,口服皮质类固醇队列发生骨折的风险显着更高(RR = 1.90,95%CI 1.68,2.16)。女性的患病风险高于男性,尤其是椎骨骨折的患病风险(RR = 5.19,95%CI 2.95,9.16)。先前的骨折,帕金森氏病和抗癫痫药物与较高的​​风险显着相关,而HRT,NSAIDS和他汀类药物与较低的风险相关。据估计,人群中口服皮质类固醇激素可导致六分之一的椎骨骨折和十三分之一的非椎骨骨折。结论:口服皮质类固醇,特别是对妇女的重要公共卫生影响,需要解决。提倡更多地使用药物来减轻这些广泛使用的药物的副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号